Literature DB >> 6134247

Pharmacological antagonism of facilitatory but not inhibitory effects of serotonin and norepinephrine on excitability of spinal motoneurons.

S R White, R S Neuman.   

Abstract

Serotonin (5HT) and norepinephrine (NE) produced long-lasting facilitation of glutamate-evoked activity of spinal motoneurons when applied iontophoretically with small ejection currents into the ventral horn. The facilitation was usually preceded by a brief period of inhibition at the onset of current application to the monoamine-containing barrels. This inhibition did not outlast the current application. Ejection of hydrogen ions produced only inhibition of glutamate-evoked activity with no subsequent facilitation at current offset. The 5HT antagonists, methysergide and metergoline, blocked the facilitation, but not the inhibition of motoneuron excitability caused by 5HT. Similarly, the alpha-adrenergic antagonists, piperoxane and phentolamine, blocked the facilitatory, but not the inhibitory, effects of NE on excitability of motoneurons. Since the inhibitory effects of 5HT and NE could not be blocked with the antagonists used, and since ejection of hydrogen ions also produced inhibition, non-specific causes for the inhibitory effects of 5HT and NE could not be rejected. However, the facilitatory effects of 5HT and NE on excitability of motoneurons were readily blocked by antagonists and were, therefore, attributed to actions on separate 5HT and NE receptors in the ventral horn.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134247     DOI: 10.1016/0028-3908(83)90168-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region.

Authors:  B Y Mileykovskiy; L I Kiyashchenko; T Kodama; Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Differential distribution of biogenic amines in the hypoglossal nucleus of the rat.

Authors:  L D Aldes; R C Chronister; L A Marco; J W Haycock; J Thibault
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 3.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  5-Hydroxytryptamine responses in neonate rat motoneurones in vitro.

Authors:  M Y Wang; N J Dun
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

5.  Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.

Authors:  Alice M Holohean; John C Hackman
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

6.  The modulation of excitatory amino acid responses by serotonin in the cat neocortex in vitro.

Authors:  S Nedergaard; I Engberg; J A Flatman
Journal:  Cell Mol Neurobiol       Date:  1987-12       Impact factor: 5.046

7.  Plateau potentials in alpha-motoneurones induced by intravenous injection of L-dopa and clonidine in the spinal cat.

Authors:  B A Conway; H Hultborn; O Kiehn; I Mintz
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

8.  Serotonergic and noradrenergic facilitation of the visceromotor reflex evoked by urinary bladder distension in rats with inflamed bladders.

Authors:  Alan Randich; Amber D Shaffer; Chelsea L Ball; Hannah Mebane
Journal:  Neurosci Lett       Date:  2008-07-17       Impact factor: 3.046

9.  Catecholamine-containing axon terminals in the hypoglossal nucleus of the rat: an immuno-electronmicroscopic study.

Authors:  L D Aldes; B Shaw; R B Chronister; J W Haycock
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

10.  Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat.

Authors:  L A Connell; D I Wallis
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.